How the Drug Industry Is Countering Diminishing Vaccine Uptake

As lockdowns have kept people at home and out of medical facilities, infant vaccination rates have dropped. As you might expect, this is bad news for the drug industry, which is likely why they’ve started promoting baseless claims that childhood vaccinations might prevent COVID-19 deaths.

Baseless Claims Seek to Bolster Vaccine Uptake

There’s absolutely no evidence for this, yet, in March 2020, they started pushing the TB vaccine, claiming it might “steel the immune system” against SARS-CoV-2. As reported by Science:¹

“Researchers in four countries will soon start a clinical trial of an unorthodox approach to the new coronavirus. They will test whether a century-old vaccine against tuberculosis (TB), a bacterial disease, can rev up the human immune system in a broad way, allowing it to better fight the virus that causes coronavirus disease 2019 and, perhaps, prevent infection with it altogether.”

In April 2020, the measles-mumps-rubella (MMR) vaccine was touted as a “major breakthrough” against COVID-19. The British Express reported:²

“Researchers at the University of Cambridge said the injection could prevent severe symptoms in people who have had it because the rubella virus has a similar structure to the coronavirus …

When they compared the rubella virus and the coronavirus the researchers found that they were 29 percent identical … The researchers have no evidence that the MMR vaccine works on COVID-19 patients but they assured ‘a study is warranted.’”

In June 2020, it was the polio vaccine’s turn in the spotlight. According to The Hill,³ tuberculosis and polio vaccines are being examined “for possible protection against COVID-19.”

Jeffrey D. Cirillo, a professor of microbial pathogenesis and immunology at Texas A&M Health Science Center, went so far as to state, “This is the only vaccine in the world that can be given to combat COVID-19 right now.”

Based on what? Based on vaccination rates in countries such as Pakistan, “where most of the population is vaccinated for tuberculosis and death rates for COVID-19 have been extremely low.” That’s it.

Meanwhile, discussions and evidence showing the benefits of vitamin C and vitamin D — as well as many other therapies — are banned and censored. This, despite significant scientific evidence actually backing their use and showing the biology by which these nutrients and therapies can prevent and/or treat this particular infection. Talk about travesty.

The oral polio vaccine, by the way, is now the primary cause of polio paralysis in the world, not wild polio.^4,5 This is an inconvenient fact that is completely ignored by most mainstream media.

Common Cold May Provide Long-Term Immunity Against COVID-19

In related news, June 12, 2020, the Daily Mail,⁶ Science Times⁷ and others⁸ reported findings from a Singaporean study⁹ led by professor Antonio Bertoletti, an immunologist with the Duke-NUS Medical School, showing common colds caused by the betacoronaviruses OC43 and HKU1 might make you more resistant to SARS-CoV-2 infection, and that the resulting immunity might last as long as 17 years.

In addition to the common cold, OC43 and HKU1 — two of the most commonly encountered betacoronaviruses¹⁰ — are also known to cause bronchitis, acute exacerbation of chronic obstructive pulmonary disease and pneumonia in all age groups.¹¹ As reported by the Daily Mail:¹²

“They share many genetic features with the coronaviruses Covid-19, MERS and SARS, all of which passed from animals to humans. Coronaviruses are thought to account for up to 30 percent of all colds but it is not known specifically how many are caused by the betacoronavirus types. 

Now scientists have found evidence that some immunity may be present for many years due to the body’s ‘memory’ T-cells from attacks by previous viruses with a similar genetic make-up — even among people who have had no known exposure to Covid-19 or SARS …

Blood was taken from 24 patients who had recovered from Covid-19, 23 who had become ill from SARS and 18 who had never been exposed to either SARS or Covid-19 …

Half of patients in the group with no exposure to either Covid-19 or SARS possessed T-cells which showed immune response to the animal betacoronaviruses, Covid-19 and SARS. This suggested patients’ immunity developed after exposure to common colds caused by betacoronavirus or possibly from other as yet unknown pathogens.”

In other words, if you’ve beat a common cold caused by a OC43 or HKU1 betacoronavirus in the past, you may have a 50/50 chance of having defensive T-cells that can recognize and help defend against SARS-CoV-2, the novel coronavirus that causes COVID-19. According to the researchers:¹³

“These findings demonstrate that virus-specific memory T-cells induced by betacoronavirus infection are long-lasting, which supports the notion that Covid-19 patients would develop long-term T-cell immunity. Our findings also raise the intriguing possibility that infection with related viruses can also protect from or modify the pathology caused by SARS-Cov-2.”

Other Studies Show Similar Results

Other studies have also discovered that many appear to have prior resistance to SARS-CoV-2. For example, a study¹⁴ published May 14, 2020, in the journal Cell, found 70% of samples obtained by the La Jolla Institute for Immunology from patients who had recovered from mild cases of COVID-19, as well as 40% to 60% of people who had not been exposed to the virus, had resistance to SARS-CoV-2 on the T-cell level.

According to the authors, this suggests there’s “cross-reactive T cell recognition between circulating ‘common cold’ coronaviruses and SARS-CoV-2.” Like Bertoletti’s study above, the Cell study found that exposure to coronaviruses responsible for the common cold appear to allow your immune system to recognize and fight off SARS-CoV-2 as well.

May 14, 2020, Science magazine reported¹⁵ these Cell findings, drawing parallels to another earlier paper¹⁶ by German investigators that had come to a similar conclusion.

That German paper,¹⁷ the preprint of which was posted April 22, 2020, on Medrxiv, found helper T cells that targeted the SARS-CoV-2 spike protein in 15 of 18 patients hospitalized with COVID-19. As reported by Science:¹⁸

“The teams also asked whether people who haven’t been infected with SARS-CoV-2 also produce cells that combat it. Thiel and colleagues¹⁹ analyzed blood from 68 uninfected people and found that 34% hosted helper T cells that recognized SARS-CoV-2.

The La Jolla team²⁰ detected this crossreactivity in about half of stored blood samples collected between 2015 and 2018, well before the current pandemic began …

The results suggest ‘one reason that a large chunk of the population may be able to deal with the virus is that we may have some small residual immunity from our exposure to common cold viruses,’ says viral immunologist Steven Varga of the University of Iowa. However, neither of the studies attempted to establish that people with crossreactivity don’t become as ill from COVID-19.

Before these studies, researchers didn’t know whether T cells played a role in eliminating SARS-CoV-2, or even whether they could provoke a dangerous immune system overreaction. ‘These papers are really helpful because they start to define the T cell component of the immune response,’ [Columbia University virologist Angela] Rasmussen says.” 

Statistician Believes Majority Are Resistant to COVID-19

Protect Your Right to Informed Consent and Defend Vaccine Exemptions

With all the uncertainty surrounding the safety and efficacy of vaccines, it’s critical to protect your right to make independent health choices and exercise voluntary informed consent to vaccination. It is urgent that everyone in America stand up and fight to protect and expand vaccine informed consent protections in state public health and employment laws. The best way to do this is to get personally involved with your state legislators and educate the leaders in your community.

Think Globally, Act Locally

National vaccine policy recommendations are made at the federal level but vaccine laws are made at the state level. It is at the state level where your action to protect your vaccine choice rights can have the greatest impact.

It is critical for EVERYONE to get involved now in standing up for the legal right to make voluntary vaccine choices in America because those choices are being threatened by lobbyists representing drug companies, medical trade associations and public health officials, who are trying to persuade legislators to strip all vaccine exemptions from public health laws.

Signing up for NVIC’s free Advocacy Portal at www.NVICAdvocacy.org gives you immediate, easy access to your own state legislators on your smartphone or computer so you can make your voice heard. You will be kept up to date on the latest state bills threatening your vaccine choice rights and will get practical, useful information to help you become an effective vaccine choice advocate in your own community.

Also, when national vaccine issues come up, you will have the up-to-date information and call-to-action items you need at your fingertips. So, please, as your first step, sign up for the NVIC Advocacy Portal.

Sources and References

• ¹ Science March 23, 2020
• ² Express April 22, 2020
• ³ The Hill June 11, 2020
• ⁴ CDC Vaccine-Derived Poliovirus
• ⁵ The Scientist November 25, 2019
• ^6, 12, 13 Daily Mail June 12, 2020
• ⁷ Science Times June 12, 2020
• ⁸ iHeart radio June 12, 2020
• ⁹ Biorxiv preprint DOI: 10.1101/2020.05.26.115832 (PDF)
• ^10, 11 J Infect Dis. 2013 Nov 15; 208(10): 1634–1642
• ^14, 20 Cell May 14, 2020 DOI: 10.1016/j.cell.2020.05.015
• ^15, 18 Science May 14, 2020
• ^16, 17, 19 Medrxiv DOI: 10.1101/2020.04.17.20061440
• ²¹ Unherd.com June 4, 2020
• ²² Unherd.com May 2, 2020

The post How the Drug Industry Is Countering Diminishing Vaccine Uptake appeared first on LewRockwell.